South and Central America Asthma Drugs Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication (Quick Relief Medications and Long-Term Control Medications), Route of Administration (Inhaled, Prefilled Syringe/Vials, and Others), and Distribution Channel (Online Pharmacies, Hospital Pharmacies, and Retail Pharmacies)
The South and Central America asthma drugs market is expected to reach US$ 2,672.86 million by 2028 from US$ 1,863.99 million in 2021; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028.
The growth of the market is due to the rising prevalence of asthma and the increasing research activities and product innovations are propelling the asthma drugs market growth. However, the unmet medical needs are hampering market growth.
Asthma is a chronic respiratory condition marked by fluctuating airflow restriction, bronchial hyperresponsiveness, and airways inflammation. According to a review paper titled “Impact of Air Pollution on Asthma Outcomes” by Tiotiu et.al., air pollution hampered asthma outcomes in adults and children. Air pollution from traffic, nitrogen dioxide (NO2), and secondhand smoking (SHS) are all substantial risk factors for the development of asthma in children. Asthma symptoms, exacerbations, and decreased lung function can be triggered by exposure to outside pollution.
A new study financed by the Environmental Protection Agency (EPA) analyzed the link between air pollution and asthma. While experts cannot determine the primary asthma-causing agent due to air pollution, evidence suggests that it suppresses genes that control the immune system to distinguish between an allergen and a hazardous foreign substance, such as a virus or bacteria. The immune system then goes into overdrive, triggering an inflammatory reaction regardless of whether the drug is toxic, resulting in asthma.
Researchers from Stanford University's Children's Center investigated the effect of air pollution on two genes involved in immunological tolerance in children from an area with high levels of pollution. They discovered that short- and long-term exposure to high amounts of carbon monoxide (CO), NO2, and PM2.5 (particulate matter) were linked to changes in these two genes, which caused asthma. These findings focused on the epigenetic impacts of air pollution exposure and could help in the development of preventative asthma medicines.
Each of these asthma research has improved the understanding of asthma in children and supplied crucial information to the EPA that can be used to protect human health and the environment. Through these research works, the drug discovery and development for asthma is being expedited which is driving the asthma drug market.
South and Central America Asthma Drugs Market Revenue and Forecast to 2028 (US$ Mn)
Get more information on this report :
SOUTH AND CENTRAL AMERICA ASTHMA DRUGS MARKET SEGMENTATION
The South and Central America asthma drugs market, by medication, is segmented into quick relief medications and long-term control medications. Based on route of administration, the South and Central America asthma drugs market is segmented into inhaled, prefilled syringe/vials, and others. Based on distribution channel, the South and Central America asthma drugs market is segmented into online pharmacies, hospital pharmacies, retail pharmacies and drugstores Geographically, the South and Central America asthma drugs market is divided into Brazil, Argentina and Rest of South and Central America.
AstraZeneca, TEVA PHARMACEUTICAL INDUSTRIES LTD, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc., Merck & Co., Inc., Koninklijke Philips N.V., Sanofi, Pfizer Inc. (Arena Pharmaceutical GmbH), Novartis AG and Abbott are among the leading companies operating in the South and Central America asthma drugs market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South and Central America Asthma Drugs Market – By Medication
1.3.2 South and Central America Asthma Drugs Market – By Route of Administration
1.3.3 South and Central America Asthma Drugs Market – By Distribution Channel
1.3.4 South and Central America Asthma Drugs Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South and Central America Asthma Drugs Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South and Central America– PEST Analysis
4.3 Expert Opinion
5. Asthma Drugs Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Environmental Implications & Genetic Implications of Air Pollution
5.1.2 More Vulnerability in Specific Ethnic Groups
5.1.3
5.1.4 Growing Prevalence of Physiological Disorders Harboring Asthma
5.2 Market Restraints
5.2.1 Unmet Medical Needs
5.3 Market Opportunities
5.3.1 Opportunities with Commercialization of Biologics
5.4 Future Trends
5.4.1 Increasing Research Activities and Product Innovations
5.5 Impact Analysis
6. Asthma Drugs Market– South and Central America Analysis
6.1 South and Central America Asthma Drugs Market Revenue Forecast and Analysis
7. Asthma Drugs Market Analysis – by Medication
7.1 Overview
7.2 Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)
7.3 Quick Relief Medications
7.3.1 Overview
7.3.2 Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Long-term Control Medications
7.4.1 Overview
7.4.2 Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
8. Asthma Drugs Market Analysis – By Route of Administration
8.1 Overview
8.2 Asthma Drugs Market Revenue Share, By Route of Administration (2021 and 2028)
8.3 Inhaled
8.3.1 Overview
8.3.2 Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
8.4 Prefilled Syringe/Vials
8.4.1 Overview
8.4.2 Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
8.5 Others (Oral, Nasal, Ophthalmic Etc.)
8.5.1 Overview
8.5.2 Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
9. Asthma Drugs Market Analysis – By Distribution Channel
9.1 Overview
9.2 Asthma Drugs Market Revenue Share, By Distribution Channel (2021 and 2028)
9.3 Online Pharmacies
9.3.1 Overview
9.3.2 Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
9.4 Hospital Pharmacies
9.4.1 Overview
9.4.2 Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
9.5 Retail Pharmacies and Drugstores
9.5.1 Overview
9.5.2 Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
10. Asthma Drugs Market – South and Central America Analysis
10.1 South and Central America: Asthma Drugs Market Revenue and Forecast to 2028
10.1.1 Overview
10.1.2 South and Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.3 South and Central America: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.1.4 South and Central America: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.1.5 South and Central America: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6 South and Central America: Asthma Drugs Market, by Country, 2021 & 2028 (%)
10.1.6.1 Brazil: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 Brazil: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2 Brazil: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.1.6.1.3 Brazil: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.1.6.1.4 Brazil: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6.2 Argentina: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Argentina: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2 Argentina: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.1.6.2.3 Argentina: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.1.6.2.4 Argentina: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6.3 Rest of South & Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Rest of South & Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2 Rest of South & Central America: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.1.6.3.3 Rest of South & Central America: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.1.6.3.4 Rest of South & Central America: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
11. Asthma Drugs Market–Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 AstraZeneca
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 GlaxoSmithKline plc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Boehringer Ingelheim International GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck & Co., Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips N.V.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Sanofi
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Pfizer Inc. (Arena Pharmaceutical GmbH)
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Novartis AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Abbott
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Common SABAs
Table 2. Commonly inhaled corticosteroids
Table 3. South and Central America: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 4. South and Central America: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 5. South and Central America: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 6. Brazil: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 7. Brazil: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 8. Brazil: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 9. Argentina: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 10. Argentina: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 11. Argentina: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of South & Central America: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of South & Central America: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of South & Central America: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 15. Organic Developments in the Asthma Drugs Market
Table 16. Inorganic Developments in the Asthma Drugs Market
Table 17. Glossary of Terms, Asthma Drugs Market
LIST OF FIGURES
Figure 1. Asthma Drugs Market Segmentation
Figure 2. Asthma Drugs Market, By Country
Figure 3. South and Central America Asthma Drugs Market Overview
Figure 4. The Long Term Control Medications Segment Held Largest Share of Mode of Service in the Asthma Drugs Market
Figure 6. South and Central America Asthma Drugs Market- Leading Country Markets (US$ Million)
Figure 7. South and Central America PEST Analysis
Figure 8. Expert Opinion
Figure 9. Impact of Low Mood/Anxiety on Asthma
Figure 10. Asthma Drugs Market Impact Analysis of Drivers and Restraints
Figure 11. South and Central America Asthma Drugs Market– Revenue Forecast and Analysis – 2020- 2028
Figure 12. Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)
Figure 13. Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Asthma Drugs Market Share, By Route of Administration, 2021 and 2028 (%)
Figure 16. Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 17. Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 18. Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 19. Asthma Drugs Market Share, By Distribution Channel, 2021 and 2028 (%)
Figure 20. Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 21. Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 22. Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 23. South and Central America: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)
Figure 24. South and Central America: Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)
Figure 25. South and Central America: Asthma Drugs Market, by Country, 2021 & 2028 (%)
Figure 26. Brazil: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Argentina: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of South & Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
- AstraZeneca
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- GlaxoSmithKline plc.
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc.
- Koninklijke Philips N.V.
- Sanofi
- Pfizer Inc. (Arena Pharmaceutical GmbH)
- Novartis AG
- Abbott
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America asthma drugs market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South and Central America asthma drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.